NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that its fourth quarter revenues climbed 31 percent year over year partially driven by a 19 percent increase in revenue for its flagship BRACAnalysis test.

The Salt Lake City-based molecular diagnostics firm brought in total revenues of $174.1 million for the three months ended June 30, compared to revenues of $133 million for the fourth quarter of 2012. It beat the consensus Wall Street estimate for revenues of $159.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.